BackLongboard Pharmaceuticals Overview
Longboard Pharmaceuticals Inc

Longboard Pharmaceuticals Price to Book Ratio

Valuation check: LBPH's P/B ratio is 8.57, above the Healthcare sector average of 6.17.

Get informed when a big investor buys or sells

+ Follow

Price to Book

8.57

Price to Book Ratio

8.57

The Price-to-Book ratio compares a company's market value to its book value. A lower P/B ratio may suggest that the stock is undervalued relative to its assets.

Price to Book (Comparison Companies)

Loading

Price to Book Ratio History

Loading

Price to Book Ratio Comparison

Loading

Longboard Pharmaceuticals (LBPH) FAQ

As of the most recent data, LBPH shows a P/B ratio of 8.57. That is above the Healthcare sector average of 6.17. Scroll down for historical charts and peer comparison views.

The Healthcare sector average P/B ratio is about 6.17. Longboard Pharmaceuticals is at 8.57, which is higher that average. That is roughly 38.8% above the sector mean. Use the comparison chart on this page to see how LBPH stacks up against individual peers as well.

Investors watch LBPH's P/B ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Longboard Pharmaceuticals's latest reading is 8.57. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.

Besides this price-to-book ratio page, Stockcircle has Longboard Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/B ratio (currently 8.57) with ownership activity and broader fundamentals.

The Healthcare average P/B ratio is about 6.17, while LBPH is at 8.57. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.